3.1 Disease activity index:
DAI is an applicable guide to quantify the severity of intestinal inflammation. A-A group showed a significant increase in DAI compared to the control group. All treated groups showed significant lower DAI compared to A-A group. Liraglutide, Sitagliptin, Sulfasalazine, CLS and CSS groups showed a mean DAI of (2.3 ± 0.5), (2.0 ± 0.3), (2.6 ± 0.4), (1.9 ± 0.5) and (1.9 ± 0.2) respectively, compared to A-A group (5.2± 0.4).